Jazz Pharmaceuticals plc Human Resources Contracts & Agreements
118 Contracts & Agreements
- Bonus & Incentive Agreements (66 contracts)
- Change of Control Agreements (6)
- Compensation Agreements (22)
- Employment Agreements (17)
- Non-Competition Agreements (1)
- Separation Agreements (1)
- Severance Agreements (2)
- Transition Agreements (3)
- Amended and Restated Non-Employee Director Compensation Policy (approved April 25, 2024) (Filed With SEC on May 2, 2024)
- Amended and Restated GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on February 28, 2024)
- Amended and Restated 2011 Equity Incentive Plan (approved November 1, 2023) (Filed With SEC on February 28, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (approved May 4, 2023) (Filed With SEC on August 9, 2023)
- Amended and Restated Executive Change in Control and Severance Benefit Plan, dated as of May 3, 2023 (Filed With SEC on August 9, 2023)
- Amended and Restated 2011 Equity Incentive Plan (approved November 2, 2022) (Filed With SEC on March 1, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (approved April 28, 2022) (Filed With SEC on August 3, 2022)
- Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011... (Filed With SEC on November 9, 2021)
- Amended and Restated Non-Employee Director Compensation Policy (approved (Filed With SEC on August 3, 2021)
- Form of Replacement Restricted Stock Unit Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)
- Form of Replacement Stock Option Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)
- Form of Restricted Stock Unit Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)
- Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011... (Filed With SEC on August 3, 2021)
- Form of U.S. Restricted Stock Unit Award Grant Notice and Form of U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011 Equity... (Filed With SEC on August 3, 2021)
- Form of Non-U.S. Performance Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Performance Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc... (Filed With SEC on August 3, 2021)
- Form of U.S. Performance Restricted Stock Unit Award Grant Notice and Form of U.S. Performance Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and... (Filed With SEC on August 3, 2021)
- Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2021) (Filed With SEC on February 23, 2021)
- Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 30, 2020) (Filed With SEC on February 23, 2021)
- Amended and Restated Non-Employee Director Compensation Policy (approved (Filed With SEC on November 2, 2020)
- Amendment to Employment Contract, dated as of April 21, 2020, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on May 5, 2020)
- Amendment to Transition and Termination Agreement, dated as of March 31, 2020, by and between Jazz Pharmaceuticals, Inc. and Michael Miller (Filed With SEC on May 5, 2020)
- Amendment to Employment Contract, dated as of February 26, 2020, by and between Jazz Pharmaceuticals Ireland Limited and Finbar Larkin (Filed With SEC on May 5, 2020)
- Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2020) (Filed With SEC on February 25, 2020)
- Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 30, 2019) (Filed With SEC on February 25, 2020)
- Employment Contract, dated as of December 14, 2019, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on February 25, 2020)
- Employment Contract, dated as of February 22, 2013, by and between Jazz Pharmaceuticals Ireland Limited and Finbar Larkin (Filed With SEC on February 25, 2020)
- Transition and Termination Agreement, dated as of November 2, 2019, by and between Jazz Pharmaceuticals, Inc. and Mike Miller (Filed With SEC on November 5, 2019)
- Amended and Restated Executive Change in Control and Severance Benefit Plan, dated as of July 31, 2019 (Filed With SEC on November 5, 2019)
- Change in Control Severance Terms, dated as of May 15, 2016, by and between Jazz Pharmaceuticals Ireland Ltd. and Patricia Carr (Filed With SEC on November 5, 2019)
- Employment Agreement, dated as of May 16, 2012 by and between Patricia Carr and Jazz Pharmaceuticals plc (Filed With SEC on November 5, 2019)
- Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (Filed With SEC on May 7, 2019)
- Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (Filed With SEC on May 7, 2019)
- Transition Employment Letter Agreement, dated as of February 6, 2019, by and between Jazz Pharmaceuticals, Inc. and Suzanne Sawochka Hooper (Filed With SEC on May 7, 2019)
- Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2019) (Filed With SEC on February 26, 2019)
- Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 31, 2018) (Filed With SEC on February 26, 2019)
- Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011 Equity... (Filed With SEC on August 7, 2018)
- Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011 Equity Incentive Plan (Filed With SEC on August 7, 2018)
- Amended and Restated Non-Employee Director Compensation Policy (approved May 3, 2018) (Filed With SEC on August 7, 2018)
- Transition and Separation Agreement by and between Jazz Pharmaceuticals, Inc. and Karen Smith, dated as of March 24, 2018 (Filed With SEC on May 8, 2018)
- Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2018) (Filed With SEC on February 27, 2018)
